(Reuters) – Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drug’s use in lung cancer in a late-stage trial …
Tag:
abstract
-
-
By John McCrank NEW YORK – Ken Griffin, the billionaire founder of Citadel Securities, one of the world’s biggest market-making firms, said on Monday he envisions the company entering the …